Prescription drug · ANDA
sirolimus NDC 65841-771
Sirolimus .5 mg/1 · Tablet, Film coated · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65841-771-01 | 6584107710165841077101 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-771-01)Marketed from Jan 15, 2014 | |
| 65841-771-05 | 6584107710565841077105 | 500 TABLET, FILM COATED in 1 BOTTLE (65841-771-05)Marketed from Jan 15, 2014 | |
| 65841-771-06 | 6584107710665841077106 | 30 TABLET, FILM COATED in 1 BOTTLE (65841-771-06)Marketed from Jan 15, 2014 | |
| 65841-771-10 | 6584107711065841077110 | 1000 TABLET, FILM COATED in 1 BOTTLE (65841-771-10)Marketed from Jan 15, 2014 | |
| 65841-771-16 | 6584107711665841077116 | 90 TABLET, FILM COATED in 1 BOTTLE (65841-771-16)Marketed from Jan 15, 2014 | |
| 65841-771-77 | 6584107717765841077177 | 10 BLISTER PACK in 1 CARTON (65841-771-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65841-771-30)Marketed from Jan 15, 2014 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- sirolimus
- Generic name (nonproprietary)
- sirolimus
- Active ingredients
- Sirolimus — .5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 65841
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201676
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Immunologic Activity (Physiologic effect)Protein Kinase Inhibitors (Mechanism)mTOR Inhibitors (Mechanism)
- Identifiers
- Product ID 65841-771_7e6e294d-cf29-40e2-91e1-9693fdcd6b6cSPL ID 7e6e294d-cf29-40e2-91e1-9693fdcd6b6cSPL set ID 82562b68-224d-482a-b399-a89b81d5eb31RxCUI 349208, 360110, 905158UNII W36ZG6FT64
- Pharmacologic class
- Kinase Inhibitor; mTOR Inhibitor Immunosuppressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N465841077101followed by a unit qualifier and the quantityPackage 65841-0771-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 65841-771
- What is NDC 65841-771?
- 65841-771 is the product NDC for sirolimus, Sirolimus .5 mg/1 tablet, film coated, listed with the FDA by Zydus Lifesciences Limited. It has 6 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- sirolimus.
- What is the active ingredient?
- Sirolimus.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 65841. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for sirolimus?
- 36 other product NDCs are listed under this name. See all sirolimus NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other sirolimus products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-902 | 60687-0902-21 |
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4449 | 70518-4449-00 |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | Rising Pharma Holdings, Inc. | 16571-806 | 16571-0806-06 |
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4376 | 70518-4376-00 |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | Camber Pharmaceuticals, Inc. | 31722-316 | 31722-0316-31 |
| Sirolimus | Sirolimus 1 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3795 | 70518-3795-00 |
| sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-772 | 65841-0772-0165841-0772-77 |
| sirolimus | Sirolimus 2 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-773 | 65841-0773-0165841-0773-77 |
| sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-351 | 68382-0351-0168382-0351-77 |
| sirolimus | Sirolimus 2 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-352 | 68382-0352-0168382-0352-77 |
Other NDCs under ANDA 201676
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-902 |
| sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-772 |
| sirolimus | Sirolimus 2 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 65841-773 |
| sirolimus | Sirolimus 1 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-351 |
| sirolimus | Sirolimus 2 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-352 |
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 68382-520 |
| sirolimus | Sirolimus .5 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4376 |